Related Experiment Video
Updated: May 17, 2026

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures
Published on: July 2, 2014
A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the
Sean M Nestor1, Erin Gibson2, Fu-Qiang Gao3
1LC Campbell Cognitive Neurology Research Unit, University of Toronto, Canada; Heart and Stroke Foundation Centre for Stroke Recovery, University of Toronto, Canada; Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Canada; University of Toronto, Institute of Medical Sciences, University of Toronto, University of Toronto, Canada; MD/PhD Program, Faculty of Medicine, University of Toronto, University of Toronto, Canada.
Abstract:
Hippocampal volumetry derived from structural MRI is increasingly used to delineate regions of interest for functional measurements, assess efficacy in therapeutic trials of Alzheimer's disease (AD) and has been endorsed by the new AD diagnostic guidelines as a radiological marker of disease progression. Unfortunately, morphological heterogeneity in AD can prevent accurate demarcation of the hippocampus. Recent developments in automated volumetry commonly use multi-template fusion driven by expert manual labels, enabling highly accurate and reproducible segmentation in disease and healthy subjects. However, there are several protocols to define the hippocampus anatomically in vivo, and the method used to generate atlases may impact automatic accuracy and sensitivity - particularly in pathologically heterogeneous samples. Here we report a fully automated segmentation technique that provides a robust platform to directly evaluate both technical and biomarker performance in AD among anatomically unique labeling protocols. For the first time we test head-to-head the performance of five common hippocampal labeling protocols for multi-atlas based segmentation, using both the Sunnybrook Longitudinal Dementia Study and the entire Alzheimer's Disease Neuroimaging Initiative 1 (ADNI-1) baseline and 24-month dataset. We based these atlas libraries on the protocols of (Haller et al., 1997; Killiany et al., 1993; Malykhin et al., 2007; Pantel et al., 2000; Pruessner et al., 2000), and a single operator performed all manual tracings to generate de facto "ground truth" labels. All methods distinguished between normal elders, mild cognitive impairment (MCI), and AD in the expected directions, and showed comparable correlations with measures of episodic memory performance. Only more inclusive protocols distinguished between stable MCI and MCI-to-AD converters, and had slightly better associations with episodic memory. Moreover, we demonstrate that protocols including more posterior anatomy and dorsal white matter compartments furnish the best voxel-overlap accuracies (Dice Similarity Coefficient=0.87-0.89), compared to expert manual tracings, and achieve the smallest sample sizes required to power clinical trials in MCI and AD. The greatest distribution of errors was localized to the caudal hippocampus and the alveus-fimbria compartment when these regions were excluded. The definition of the medial body did not significantly alter accuracy among more comprehensive protocols. Voxel-overlap accuracies between automatic and manual labels were lower for the more pathologically heterogeneous Sunnybrook study in comparison to the ADNI-1 sample. Finally, accuracy among protocols appears to significantly differ the most in AD subjects compared to MCI and normal elders. Together, these results suggest that selection of a candidate protocol for fully automatic multi-template based segmentation in AD can influence both segmentation accuracy when compared to expert manual labels and performance as a biomarker in MCI and AD.
Insights
Choosing the right hippocampal labeling protocol is crucial for accurate Alzheimer's disease (AD) diagnosis and clinical trials. More inclusive protocols improve accuracy and sensitivity in distinguishing disease stages.
Area of Science:
- Neuroimaging
- Alzheimer's Disease Research
- Medical Diagnostics
Background:
- Structural MRI-based hippocampal volumetry is vital for Alzheimer's disease (AD) diagnosis and therapeutic trial efficacy.
- Morphological heterogeneity in AD complicates accurate hippocampal demarcation.
- Automated volumetry using multi-template fusion offers high accuracy and reproducibility.
Purpose of the Study:
- To evaluate the performance of five common hippocampal labeling protocols for automated multi-atlas based segmentation in AD.
- To compare the accuracy and sensitivity of different protocols in distinguishing between normal elders, mild cognitive impairment (MCI), and AD.
- To determine which protocols are most suitable for powering clinical trials in MCI and AD.
Main Methods:
- A fully automated segmentation technique was developed and tested using data from the Sunnybrook Longitudinal Dementia Study and the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI-1).
- Five distinct hippocampal labeling protocols were implemented and compared head-to-head.
- Manual tracings by a single operator served as the 'ground truth' for comparison.
Main Results:
- All tested protocols differentiated between normal elders, MCI, and AD, showing comparable memory correlations.
- More inclusive protocols accurately distinguished between stable MCI and MCI-to-AD converters.
- Protocols incorporating posterior anatomy and dorsal white matter achieved superior Dice Similarity Coefficients (0.87-0.89) and required smaller sample sizes for clinical trials.
Conclusions:
- The selection of a hippocampal labeling protocol significantly impacts automated segmentation accuracy and biomarker performance in AD.
- Protocols including more posterior and dorsal white matter regions demonstrate higher accuracy and efficiency for clinical trials.
- Accuracy differences among protocols were most pronounced in AD subjects compared to MCI and normal elders.
More Related Videos
11:03High-resolution In Vivo Manual Segmentation Protocol for Human Hippocampal Subfields Using 3T Magnetic Resonance Imaging
Published on: November 10, 2015
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018